Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mayrhofer

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Computed Tomography|May 23, 2019
Non-invasive fractional flow reserve derived from coronary computed tomography angiography in patients with acute chest pain: Subgroup analysis of the ROMICAT II trialMaros Ferencik, Michael T Lu, Thomas Mayrhofer, et al.
Kidney International|January 21, 2026
Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1qGeorg W Sendtner, Julia Miranda, Pia Naumann, et al.
European Heart Journal. Cardiovascular Imaging|August 29, 2025
Sex-Specific Prognostic Value of Automated Epicardial Adipose Tissue Quantification on Serial Lung Cancer Screening Chest CTJan M Brendel, Thomas Mayrhofer, Ibrahim Hadzic, et al.
Journal of Cardiovascular Computed Tomography|March 19, 2025
Air pollution, coronary artery disease, and cardiovascular events: Insights from the PROMISE trialMarcel C Langenbach, Thomas Mayrhofer, Isabel L Langenbach, et al.
JACC. Cardiovascular Imaging|November 18, 2019
Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISEDaniel O Bittner, Thomas Mayrhofer, Matt Budoff, et al.
European Radiology|September 7, 2017
Age- and sex-based resource utilisation and costs in patients with acute chest pain undergoing cardiac CT angiography: pooled evidence from ROMICAT II and ACRIN-PA trialsFabian Bamberg, Thomas Mayrhofer, Maros Ferencik, et al.
European Heart Journal. Cardiovascular Imaging|December 7, 2018
Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trialBorek Foldyna, James E Udelson, Júlia Karády, et al.
JAMA Cardiology|December 22, 2021
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE TrialLili Zhang, Devvora Olalere, Thomas Mayrhofer, et al.
Clinical Chemistry|September 20, 2017
High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest PainMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
JACC. Cardiovascular Imaging|August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial ResultsMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Computed Tomography|May 23, 2019
Non-invasive fractional flow reserve derived from coronary computed tomography angiography in patients with acute chest pain: Subgroup analysis of the ROMICAT II trialMaros Ferencik, Michael T Lu, Thomas Mayrhofer, et al.
Kidney International|January 21, 2026
Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1qGeorg W Sendtner, Julia Miranda, Pia Naumann, et al.
European Heart Journal. Cardiovascular Imaging|August 29, 2025
Sex-Specific Prognostic Value of Automated Epicardial Adipose Tissue Quantification on Serial Lung Cancer Screening Chest CTJan M Brendel, Thomas Mayrhofer, Ibrahim Hadzic, et al.
Journal of Cardiovascular Computed Tomography|March 19, 2025
Air pollution, coronary artery disease, and cardiovascular events: Insights from the PROMISE trialMarcel C Langenbach, Thomas Mayrhofer, Isabel L Langenbach, et al.
JACC. Cardiovascular Imaging|November 18, 2019
Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISEDaniel O Bittner, Thomas Mayrhofer, Matt Budoff, et al.
European Radiology|September 7, 2017
Age- and sex-based resource utilisation and costs in patients with acute chest pain undergoing cardiac CT angiography: pooled evidence from ROMICAT II and ACRIN-PA trialsFabian Bamberg, Thomas Mayrhofer, Maros Ferencik, et al.
European Heart Journal. Cardiovascular Imaging|December 7, 2018
Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trialBorek Foldyna, James E Udelson, Júlia Karády, et al.
JAMA Cardiology|December 22, 2021
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE TrialLili Zhang, Devvora Olalere, Thomas Mayrhofer, et al.
Clinical Chemistry|September 20, 2017
High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest PainMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
JACC. Cardiovascular Imaging|August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial ResultsMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
Pageof 10